Projected Income Statement: Procter & Gamble Company

Forecast Balance Sheet: Procter & Gamble Company

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 21,700 24,279 26,361 22,978 24,952 24,072 22,914 21,235
Change - 11.88% 8.58% -12.83% 8.59% -3.53% -4.81% -7.33%
Announcement Date 7/30/21 7/29/22 7/28/23 7/30/24 7/29/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: Procter & Gamble Company

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 2,787 3,156 3,062 3,322 3,773 3,928 3,934 4,047
Change - 13.24% -2.98% 8.49% 13.58% 4.11% 0.17% 2.86%
Free Cash Flow (FCF) 1 15,584 13,567 13,786 16,524 14,606 15,764 16,131 17,528
Change - -12.94% 1.61% 19.86% -11.61% 7.93% 2.33% 8.66%
Announcement Date 7/30/21 7/29/22 7/28/23 7/30/24 7/29/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Procter & Gamble Company

Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 27.22% 25.71% 25.42% 27.23% 27.65% 27.85% 28.19% 28.66%
EBIT Margin (%) 23.63% 22.21% 22.11% 23.78% 24.27% 24.31% 24.63% 25%
EBT Margin (%) 23.14% 22.44% 22.38% 22.32% 23.93% 24.29% 25% 25.87%
Net margin (%) 18.79% 18.38% 17.87% 17.7% 18.95% 19.4% 19.5% 19.9%
FCF margin (%) 20.47% 16.92% 16.81% 19.66% 17.33% 18.14% 18.03% 18.96%
FCF / Net Income (%) 108.93% 92.03% 94.08% 111.06% 91.44% 93.47% 92.43% 95.26%

Profitability

        
ROA 11.92% 12.47% 12.31% 13.39% 12.9% 13.35% 13.32% 13.59%
ROE 30.59% 31.53% 31.2% 30.48% 31.06% 31.55% 31.53% 32.93%

Financial Health

        
Leverage (Debt/EBITDA) 1.05x 1.18x 1.26x 1x 1.07x 0.99x 0.91x 0.8x
Debt / Free cash flow 1.39x 1.79x 1.91x 1.39x 1.71x 1.53x 1.42x 1.21x

Capital Intensity

        
CAPEX / Current Assets (%) 3.66% 3.94% 3.73% 3.95% 4.48% 4.52% 4.4% 4.38%
CAPEX / EBITDA (%) 13.45% 15.31% 14.69% 14.52% 16.19% 16.23% 15.6% 15.28%
CAPEX / FCF (%) 17.88% 23.26% 22.21% 20.1% 25.83% 24.92% 24.39% 23.09%

Items per share

        
Cash flow per share 1 7.063 6.586 6.783 8.029 7.259 8.054 8.662 9.424
Change - -6.75% 2.99% 18.37% -9.58% 10.95% 7.54% 8.8%
Dividend per Share 1 3.242 3.523 3.681 3.829 4.076 4.306 4.501 4.72
Change - 8.67% 4.47% 4.02% 6.47% 5.62% 4.53% 4.88%
Book Value Per Share 1 19.2 19.57 19.8 20.45 21.3 23.3 24.58 25.16
Change - 1.93% 1.18% 3.28% 4.15% 9.39% 5.49% 2.36%
EPS 1 5.5 5.81 5.9 6.02 6.51 6.946 7.235 7.687
Change - 5.64% 1.55% 2.03% 8.14% 6.7% 4.15% 6.26%
Nbr of stocks (in thousands) 2,448,233 2,399,297 2,356,969 2,360,135 2,344,542 2,336,734 2,336,734 2,336,734
Announcement Date 7/30/21 7/29/22 7/28/23 7/30/24 7/29/25 - - -
1USD
Estimates
2026 *2027 *
P/E ratio 20.6x 19.7x
PBR 6.13x 5.81x
EV / Sales 4.12x 3.99x
Yield 3.01% 3.15%
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
142.84USD
Average target price
168.50USD
Spread / Average Target
+17.96%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. PG Stock
  4. Financials Procter & Gamble Company